ImmunityBio, Inc.

IBRX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
172
SEC Filings

Business Summary

PART I . Forward-Looking Statements This Annual Report contains forward-looking statements within the meaning of Section27A of the Securities Act and Section21E of the Exchange Act that are based on our managements beliefs and assumptions and on information currently available to our management. Forward-looking statements include, but are not limited to: our ability to successfully commercialize ANKTIVA globally in NMIBC, NSCLC or other indications or any future approved products in the U.S. or ...

Next Earnings

Q2 FY2026 — expected 2026-08-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIBRXdiscussed_in_filing Cybersecurity
topic_mentionIBRXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-232025-12-310001326110-26-000030EDGAR153K words
2025-03-032024-12-310001326110-25-000033EDGAR—
2024-03-192023-12-310001326110-24-000037EDGAR—
2023-03-012022-12-310001326110-23-000018EDGAR—
2022-03-012021-12-310001326110-22-000011EDGAR—
2021-03-042020-12-310001564590-21-010945EDGAR—
2020-03-252019-12-310001564590-20-012816EDGAR—
2019-03-132018-12-310001564590-19-007562EDGAR—
2018-03-122017-12-310001564590-18-005290EDGAR—
2017-03-152016-12-310001564590-17-004430EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001326110-25-000139EDGAR110K words
2025-08-052025-06-300001326110-25-000114EDGAR—
2025-05-122025-03-310001326110-25-000071EDGAR—
2024-11-122024-09-300001326110-24-000111EDGAR—
2024-08-122024-06-300001326110-24-000103EDGAR—
2024-05-092024-03-310001326110-24-000064EDGAR—
2023-11-092023-09-300001326110-23-000147EDGAR—
2023-08-082023-06-300001326110-23-000098EDGAR—
2023-05-112023-03-310001326110-23-000064EDGAR—
2022-11-092022-09-300001326110-22-000074EDGAR—
2022-08-082022-06-300001326110-22-000058EDGAR—
2022-05-102022-03-310001326110-22-000027EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060001193125-26-142932EDGAR1K words
2026-03-310001193125-26-133363EDGAR—
2026-02-230001326110-26-000025EDGAR—
2026-02-180001326110-26-000018EDGAR—
2026-01-260001326110-26-000014EDGAR—
2026-01-150001326110-26-000008EDGAR—
2026-01-140001326110-26-000004EDGAR—
2025-12-290001193125-25-331244EDGAR—
2025-12-150001326110-25-000146EDGAR—
2025-12-120001326110-25-000143EDGAR—

172 total filings indexed. 140 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001326110
TickerIBRX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6b7c800c4c51f13e8639aa4d76853e3d271d20b86067e19f0d1b7a7c108ee1e9
parent: bad623399bebeafb1fe4077361c2054b8759ffe1c7df2e067d5f1d5e7f5da7c5
content hash: 7324446290aea138c078d868face49aa63dcd09c72bd7dff5e830c9a8a225218
signed: 2026-04-13T04:45:37.066Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf